BioSoteria, Inc. a leading provider of drug safety and risk management consulting services and training, announces the release of the Scientific Program and opening of conference registration for the third annual Pacific Drug Safety Summit, to be held at the Mission Bay Conference Center at UCSF, San Francisco, on September 25, 2009.
Since its inception, the Pacific Drug Safety Summit has grown to be one of the largest and most successful West Coast drug safety and pharmacovigilance conferences and networking events. Drug safety professionals and service providers alike keep coming back to PDSS each year due to the quality of the presentations, the diversity of the speakers and topics, and the opportunity to network with more than 100 drug safety practitioner attendees and numerous vendors sponsoring the event.
This year’s event offers eight contemporary topics presented by internationally known thought-leaders in drug safety and pharmacovigilance. Topics and invited speakers include the following:
Morning Keynote: Quantitative Safety Signal Detection: CIOMS Working Group VIII
Andrew Bate, PhD, MA
Director, Quantitative Epidemiologist, Pfizer, Inc.
Quantitative Risk Benefit Assessment
Paul Coplan, Sc.D, MBA
Senior Director, Risk Management, Global Safety Surveillance and Epidemiology, Wyeth Pharmaceuticals
Religion and Politics: Controversial issues in Data Monitoring Committees
David Kerr, MS, Project Director, Axio Research
Use of Electronic Health Record Data in Pharmacovigilance
Robert Dubois, MD, PhD
Chief Medical Officer, Cerner Life Sciences
Afternoon Keynote: International Drug Safety Landscape: Challenge and an Opportunity for Change
Rebecca Wang MD, FRCP, FACC
Head, Regional Center, Asia Pacific Pharma Development, Drug Safety Operation, Roche
Online Capture of AEs from Call Centers and Import into Safety Systems
Partner, Foresight Group
Risk Management Plan (RMP) for Extraneal
Robin Geller, PhD
Director of Risk Management, Global Pharmacovigilance, Baxter Healthcare Corporation
Post-marketing Studies and Registries Associated with REMS
Cathy Sigler, DVM, PhD
Sr. Director, Safety, Epidemiology, Registries, & Risk Management, United BioSource Corporation
Attendees will have the opportunity throughout the event to participate in networking breaks and a panel discussion, as well as interact with a diverse assemblage of drug safety and pharmacovigilance attendees and sponsoring vendors. Breakfast and lunch will also be served and is included in the registration fee.
Due to the generous support of the conference sponsors, BioSoteria is able to again offer an affordable registration fee for conference attendees. The early bird registration fee to attend this full, one-day conference is $225 for those who register by Monday, August 31; the full registration fee is $295 for those who register after August 31. Questions about registration may be directed to PDSS Conference Planner Email or 1-866-660-5553. Online registration and more information are available at pacificdrugsafetysummit.com.
Conference Sponsors to date include the following:
• APCER Pharma Solutions
• Aris Global
• Axio Research
• Cerner Galt
• Drug Logic
• Foresight Group
• November Research Group
• Phase Forward
• United BioSource Corporation (UBC).
Space remains for a few additional sponsors, although exhibit space is filling quickly. To learn more, contact the conference host BioSoteria at contact[.]biosoteria.com or 1-866-660-5553 x010 today to reserve your sponsorship at the one of the largest drug safety conferences and networking events held in the Western U.S.
Venue and Lodging
BioSoteria, Inc., the conference organizer (pacificdrugsafetysummit.com), is pleased to host this year’s event at the new, state-of-the-art Mission Bay Conference Center at UCSF. Centered in UCSF’s new 43-acre life sciences campus for teaching and research, the Conference Center is located just south of downtown in San Francisco. A block of rooms have been reserved at the Hotel Griffon. Visit the website for more information about the conference venue and hotel.
BioSoteria (biosoteria.com) delivers high quality, innovative drug safety, pharmacovigilance, and therapeutic risk management consultant services and educational programs to the biopharmaceutical and healthcare community. For more information about BioSoteria and our services and educational programs, please email contact[.]biosoteria.com, visit our website, or call.